Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity

NIH RePORTER · NIH · R01 · $394,224 · view on reporter.nih.gov ↗

Abstract

Varicella-zoster virus is an alpha-herpesvirus that causes varicella and zoster. Infection of T cells allows VZV transfer from the respiratory tract to skin and the typical herpes zoster rash results from axonal transport after VZV reactivation in neurons. Our research program investigates the mechanisms of VZV take-over of its target cells, focusing on infection of primary human tonsil T cells and adult skin xenografts in the severe combined immunodeficiency (SCIO) mouse model. We plan to pursue our longstanding objective to understand of VZV pathogenesis in new directions that are designed to determine the role of activation of protein kinase R in VZV infection, the effects of complement as an innate defense against VZV infection of tonsil T cells and VZV countermeasures, and glycoprotein-mediated mechanisms of VZV entry into T cells. This work is expected to provide new knowledge about the takeover of host cell signaling pathways by VZV to support its replication, the regulation of VZV pathogenesis by innate host responses and how VZV overcomes these barriers, and the functions of VZV glycoproteins during infection of differentiated human cells, all of which are critical for VZV infection of the human host. RELEVANCE (See instructions):

Key facts

NIH application ID
9968744
Project number
4R01AI020459-37
Recipient
STANFORD UNIVERSITY
Principal Investigator
Stefan Lyne Oliver
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$394,224
Award type
4C
Project period
1994-08-01 → 2024-01-31